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Objectives This study sought to evaluate the effect of systematic data analysis and standardized
feedback on treatment times and outcome in a prospective multicenter trial.
Background Formalized data feedback may reduce treatment times in ST-segment elevation myo-
cardial infarction (STEMI).
Methods Over a 15-month period, 1,183 patients presenting with STEMI were enrolled. Six primary
percutaneous coronary intervention hospitals in Germany and 29 associated nonpercutaneous coro-
nary intervention hospitals participated. Data from patient contact to balloon inﬂation were col-
lected and analyzed. Pre-deﬁned quality indicators, including the percentage of patients with pre-
announced STEMI, direct handoff in the catheterization laboratory, contact-to-balloon time 90 min,
door-to-balloon time 60 min, and door-to-balloon time 30 min were discussed with staff on a
quarterly basis.
Results Median door-to-balloon time decreased from 71 to 58 min and contact-to-balloon time
from 129 to 103 min between the ﬁrst and the ﬁfth quarter (p  0.05 for both). Contributing were
horter stays in the emergency department, more direct handoffs from ambulances to the catheter-
zation laboratory (from 22% to 38%, p  0.05), and a slight increase in the number of patients
ransported directly to the percutaneous coronary intervention facility (primary transport). One-
ear mortality was reduced in the total group of patients and in the subgroup of patients with
rimary transport (p  0.05). The sharpest fall in mortality was observed in patients with pri-
ary transport and TIMI (Thrombolysis In Myocardial Infarction) risk score 3 (n  521) with a
ecrease in 30-day mortality from 23.1% to 13.3% (p  0.05) and in 1-year mortality from 25.6%
o 16.7% (p  0.05).
onclusions Formalized data feedback is associated with a reduction in treatment times for STEMI
nd with an improved prognosis, which is most pronounced in high-risk patients. (Feedback Inter-
ention and Treatment Times in ST-Elevation Myocardial Infarction [FITT-STEMI]; NCT00794001)
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849Current guidelines stress the importance of a system of care
for ST-segment elevation myocardial infarction (STEMI)
that optimally includes acquiring a pre-hospital electrocar-
diogram (ECG), transmitting this ECG to a percutaneous
coronary intervention (PCI) center, and initiating adequate
and rapid reperfusion therapy (1–4). Several trials have
established the importance of minimizing treatment times
for STEMI patients (5,6). In real-world settings, contact-
to-balloon (C2B) times frequently exceed the established
target of 120 min (7) and door-to-balloon (D2B) times
often exceed 90 min (8). Efforts to reduce these times have
resulted in recommendations that include implementing
regional STEMI networks and providing feedback (9). In a
previous single-center project, we demonstrated that treat-
ment times were reduced in a regional STEMI network
after implementing systematic data analysis with quarterly
interactive feedback to all network participants (10). The
current multicenter, prospective study, the FITT-STEMI
(Feedback Intervention and Treatment Times in ST-
Elevation Myocardial Infarction) trial, was designed to
determine the effect of systematic data analysis and stan-
dardized feedback intervention on treatment times and
outcomes across several different regional care STEMI
networks.
Methods
Participating hospitals. Six hospitals with primary PCI ca-
pacity and 29 cooperating non-PCI hospitals participated.
Inclusion requirements included 24-h PCI capability for at
least 1 year before inclusion, 2 interventional cardiologists
who could take calls, 250 PCI procedures, as well as 50 PCI
procedures in STEMI patients per year. Before participat-
ing in the project, all 6 key strategies of the American
College of Cardiology D2B initiative (emergency depart-
ment [ED] physician activates the catheterization lab;
single-call activation system activates the catheterization
lab; catheterization lab team is available within 20 to 30
min; prompt data feedback occurs; senior management
honor commitment; team-based approach is used) were
endorsed by the hospitals. All hospitals ensured prompt
transfer of patients with STEMI to the PCI centers,
minimizing time to treatment. Institutional protocols were
in place that aimed to: 1) obtain pre-hospital 12-lead ECG;
2) bypass non-PCI hospitals; and 3) bypass the ED with
direct transfer to the cardiac catheterization laboratory when
feasible. The overall geographic catchment area served a
Darmstadt, Germany; ¶Department of Cardiology, Asklepios Klinik Langen,
Langen, Germany; #Department of Cardiology, University of Vermont, Burling-
ton, Vermont; **Department of Cardiology and Pneumology, Georg-August-
University Göttingen, Göttingen, Germany; and the ††Department of Medical
Statistics, Georg-August-University Göttingen, Göttingen, Germany. Supported
by grants from the Deutsche Herzstiftung and the Arbeitsgemeinschaft Leitender
M
apopulation of 2 million with more than 1,000 STEMI
patients per year (Table 1).
Patient inclusion. All patients who were diagnosed with
ST-segment elevations (1–3) or with new left bundle branch
block with typical symptoms of at least 30 min with the
intention to perform primary PCI were included. The only
exclusion criteria were the duration of symptoms or the
documentation of ST-segment elevations 24 h. Patients
in cardiogenic shock and patients who were undergoing or
had undergone cardiopulmonary resuscitation were not
excluded. Patients intended to have angiography and PCI
were included even if they did not ultimately have either of
these procedures.
Study protocol, data assessment, and outcome measures.
The study was approved by the ethics committee of the
University of Göttingen. The study protocol consisted of a
prospective design over 5 consecutive 3-month periods
(quarters) with the first quarter being the reference quarter.
Data were collected from October 2007 on, using a web-
based system with independent monitoring for data valida-
tion (“source data verification”).
Time points from initial contact
with the medical system to bal-
loon inflation, including time of
arrival on scene, out-of-hospital-
treatment time, transport to the
hospital, transfer to the catheter-
ization laboratory, puncture, and
first balloon inflation were as-
sessed (Fig. 1). From these data
and additional information, risk
stratification by TIMI (Throm-
bolysis In Myocardial Infarc-
tion) risk score was performed.
Clinical endpoints were assessed at the time of discharge, at
30 days, and at 1 year with telephone follow-up.
The primary outcome was C2B. Secondary outcome
measures included D2B, mortality, and New York Heart
Association functional class. Outcomes are generally re-
ported as results in Quarter 5 compared with results in
Quarter 1.
Formalized data feedback. Quarterly feedback was per-
formed during the first month of each quarter beginning in
the second quarter. It consisted of interactive sessions with
participants involved in the treatment or referral of STEMI
patients, including emergency medical service, ED, and
catheterization lab staff; interventional cardiologists; and
ardiologischer Krankenhausarzte (to Dr. Scholz). Dr. Maier is funded by the
eutsche Forschungs Gemeinschaft through a Heisenberg grant (MA 1982/4-1).
ll other authors have reported that they have no relationships relevant to the
ontents of this paper to disclose.
anuscript received March 9, 2012; revised manuscript received April 5, 2012,
Abbreviations
and Acronyms
C2B  contact-to-balloon
D2B  door-to-balloon
ECG  electrocardiogram
ED  emergency department
PCI  percutaneous
coronary intervention
STEMI  ST-segment
elevation myocardial
infarctionccepted April 12, 2012.
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850staff of the emergency responding system. The formalized
feedback presentations were prepared centrally by the study
initiator and staff, including a standardized set of 30 slides.
Slide presentations included descriptive statistics regarding
clinical characteristics and means of transportation. The
following pre-defined key quality indicators were presented
in quarterly analyses: percentage of patients with telephone
announcement in advance; patients with telemetry-ECG
transmission; patients who bypassed the ED with direct
handoff in the catheterization lab; average and median
components of treatment times, including time intervals
from the first medical contact to balloon inflation with
separate analyses for different patient subgroups, percentage
of patients with C2B 120 min and 90 min, and
percentage of patients with D2B 30 min, D2B 60 min,
and D2B 90 min. Emphasis was placed on comparing
D2B times in the group of patients who bypassed the ED
with direct handoff in the catheterization lab with D2B
times in the group who did not bypass the ED. Data
assessment was continued for 2 years after the fifth quarter.
Statistics. Mean and median values are presented. The
istributions of time intervals are graphically presented as
aplan-Meier estimates. The Gehan test was used for
etween-group comparisons. This is equivalent to the
ruskal-Wallis test and to the Wilcoxon-Mann-Whitney
est for uncensored data. Categorical data are presented as
requencies and percentages, and groups were compared
Table 1. Characteristics of PCI Hospitals and Systems of Care for Patients
Variable PCI Hospital
24-h PCI service 
Number of cooperating non-PCI hospitals in treating STEMI 9
Established MI network 
Assessment of treatment times in STEMI patients* 
Number of interventional cardiologists sharing call 7
Number of PCIs performed annually 800
Number of PCIs performed for STEMI per year 151
Catchment area (estimated population) 600,000
Catchment area
Urban
Rural
Mixed 
Number of ambulances with 12-lead ECG machines 10
Number of pre-hospital 12-lead-ECG machines capable for telemetry 
Maximal transport distance, km 80
Maximal transport time, min 60
Means of transport
Ambulance 
Helicopter 
*Before start of FITT-STEMI participation.
ECG electrocardiogram; FITT Feedback Intervention and Treatment Times;MImyocardial ising the Pearson chi-square test. The statistical softwareTATISTICA (StatSoft Inc., Tulsa, Oklahoma) was used.
value of p  0.05 was considered significant.
In addition, a nonparametric analysis of variance test for
imely trend was computed (SAS-Macro LD_F1.SAS) and
he corresponding p value presented for outcome data
mortality and New York Heart Association functional class I)
11). This test is based on a repeated measures design taking
he data of all quarters and of all individual institutions into
ccount. In this analysis, the centers are the subjects in a
-level plot factor, and the quarters constitute the levels of
he time factor in ascending order (12).
esults
Patient characteristics. This study included 1,183 patients
with STEMI (Online Table 1). Seventy-four percent of the
patients were men, and the total mean age was 63  13
years. One-third of patients were classified into TIMI risk
scores 0 to 2, 3 to 4, and 5 to 8, respectively, with an average
TIMI risk score of 3.9  2.5. The patient population
included 14% of patients presenting with cardiogenic shock,
9% having had pre-hospital cardiopulmonary resuscitation,
and 8% receiving intra-aortic balloon counterpulsation. The
average in-hospital mortality was 9.9%. Thrombolysis was
performed in 3.0% of patients before PCI.
Most patients (67%) were transported directly to the PCI
center by ambulance (primary transport); secondary trans-
port occurred in 23%; 8% were self-referred; and 2% had a
Acute Myocardial Infarction
I Hospital B PCI Hospital C PCI Hospital D PCI Hospital E PCI Hospital F
    
2 2 2 12 2
    
    
3 4 4 6 3
360 700 1,130 1,000 500
82 133 159 307 118
150,000 150,000 300,000 500,000 300,000


  
3 1 3 11 2
 1   
30 20 25 60 30
30 20 30 60 30
    
  
n; PCIpercutaneous coronary intervention; STEMI ST-segment elevationmyocardial infarction.With
A PCSTEMI during a hospital stay in a PCI center (Online
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851Table 2). The proportion of patients transported directly to
the PCI facility was greater in the fifth quarter (73%), along
with a reduction in patients brought by secondary transport
(19%). In 99% of patients, coronary angiography was
performed, with 85% of these resulting in primary PCI
Figure 1. Documentation Sheet Used for All STEMI Patients (Originally in G
ACE-I  angiotensin-converting enzyme inhibitor; ARB  angiotensin recep
ease; Cath  catheterization; CPR  cardiopulmonary resuscitation; CVA 
ECG  electrocardiogram; EMS  emergency medical services; ER  emerg
glycoprotein; HTN  hypertension; IABP  intra-aortic balloon pump; LAD
main artery; MI  myocardial infarction; PCI  percutaneous coronary inte
patient; RCA  right coronary artery; STEMI  ST-segment elevation myoca
disease; VF  ventricular ﬁbrillation.(Online Table 1).Primary outcomes: treatment times. Median C2B time de-
creased from 129 (Quarter 1) to 103 min (Quarter 5; p 
0.05) (Fig. 2A). Median D2B times decreased from 71 to 58
min (p  0.05). Mean C2B times decreased from 165 to
125 min, and D2B times from 89 to 66 min (p  0.05,
n)
locker; CABG  coronary artery bypass graft; CAD  coronary artery dis-
rovascular accident; Deﬁbrill  deﬁbrillation; DM  diabetes mellitus;
department; FITT  Feedback Intervention and Treatment Times; GP 
t anterior descending artery; LCx  left circumﬂex artery; LMain  left
on; PMD  private medical doctor; PMHx  patient medical history; Pt 
infarction; TIMI  Thrombolysis In Myocardial Infarction; VD  vesselerma
tor b
cereb
ency
 lef
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852farction network (e.g., small vs. large, community vs. uni-
versity hospitals). When comparing treatment times in
Hospitals A and E versus Hospitals B, C, D, and F, both
D2B and C2B improved similarly (data not shown). The
proportion of patients who were treated within the
guideline-recommended C2B time of 120 min was 44%
in the first quarter and increased to 63% in the fifth quarter
(p  0.05) (Fig. 2B) compared with an increase from 19%
o 35% (p  0.05, data not shown) for a C2B time of 90
in. The proportion of patients with a D2B time of 90
in increased from 65% to 82% (p  0.05) (Fig. 2C).
The largest time decrement overall was due to an im-
rovement in the door-to-catheterization laboratory time,
eflecting to a large extent less time spent in the ED
median decrease from 32 to 23 min; p  0.05) (Fig. 2A).
he percentage of patients that bypassed the ED increased
rom 22% to 38% (p  0.05) (Fig. 3). For patients who
nderwent primary transport, ED bypass rates increased
Figure 2. Treatment Times (STEMI Patients With PCI; N  1,002)
(A) Time components of contact-to-balloon (C2B) time, including door-to-ballo
median. (B) Percentage of patients with STEMI and PCI that were treated with
of 90 min. Abbreviations as in Figure 1.rom 19% to 37% (p  0.05) and for those with secondaryransport, bypass rates went from 39% to 58% (p  0.06).
y contrast, there was a small, but not significant, increase
n the number of pre-announced patients in both subgroups
myocardial infarction called in) (Online Table 2).
Consistent with these results, D2B times were markedly
educed in patients who bypassed the ED, with 36 min as
ompared to 87 min for those patients who did not bypass
he ER (median: 34 vs. 72 min; p  0.05; data not shown).
n the group of transfer patients, no improvements were
ound in door-to-door, first-door-to-balloon, or in C2B
imes (Table 2).
Secondary outcomes: mortality and heart failure. There was
a trend toward decreased in-hospital mortality (p  0.28)
(Fig. 4) and 30-day mortality (p  0.15) (Online Fig. 1A),
whereas 1-year mortality significantly decreased from 14.9%
(Quarter 1) to 12.5% (Quarter 5; p  0.05) (Online Fig.
1B). In the subgroup of high-risk patients (TIMI risk score
3), 1-year mortality decreased from 22.7% (Quarter 1) to
2B) time in all 1,002 patients with STEMI and PCI. Times are presented as
time of 120 min. (C) Percentage of patients that were treated with a D2Bon (D
a C2B17.6% (Quarter 5, p  0.05) (Online Table 3). There was a
tt
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853significant reduction in 30-day mortality (p  0.05) with a
rend toward decreased in-hospital mortality (p  0.07).
The proportion of patients free from heart failure (New
York Heart Association functional class I) at 1 year
tended to be higher for those enrolled in the fifth quarter
than for those enrolled in the first quarter (51.5% vs.
45.6%, p  0.05) (Online Fig. 1B).
Among the largest pre-specified subgroup of patients,
hose who underwent primary transport, the 1-year mortal-
ty decreased significantly from 17.0% in Quarter 1 to 11.8%
n Quarter 5 (p  0.05) (Online Table 3). Patients with
primary transport and a TIMI risk score 3 showed a
relative 40% decrease in mortality in-hospital from 20.5% to
12.5% (p  0.05), at 30 days from 23.1% to 13.3% (p 
0.05), and at 1-year follow-up from 25.6% to 16.7% (p 
0.05) (Online Table 3). In this group of patients, C2B times
improved by 33 min. By contrast, mortality did not change
in the group of transfer patients.
Seventy-six percent of patients with primary transport
were pre-announced to the PCI center by telephone before
their arrival. The 30-day mortality in this group was 13.7%
(Quarter 1) and decreased to 5.5% (Quarter 5; p  0.05)
(Fig. 5A). The 1-year mortality decreased from 16.1% to
7.8% (p  0.05).
In parallel, these patients were increasingly likely to be
handed off directly by the ambulance crew to the cardiac
catheterization staff (28% in Quarter 1, 49% in Quarter 5;
p  0.05) (Fig. 5B). Average C2B in this subgroup decreased
from 130 min (Quarter 1) to 96 min (Quarter 5; p 0.05), and
average D2B decreased from 83 to 55 min (p  0.05).
Discussion
The present study demonstrates that formalized data assess-
Figure 3. Percentage of Patients That Bypassed the
Emergency Department (All STEMI Patients; N  1,183)
Abbreviations as in Figure 1.ment and feedback analyzing pre-defined key quality indi-cators is feasible in different regional STEMI networks and
can be associated with a marked reduction in treatment
times for STEMI patients (D2B and C2B). Reduced
treatment times were associated with a significant reduction
in 1-year mortality.
These results validate a prior single-network analysis that
included 1 PCI hospital and 2 small community hospitals
(10). The current study included a greater variety of settings,
rural and urban, academic and nonacademic, in northern
and central Germany.
The primary outcome was a reduction in STEMI treat-
ment times. Between the baseline quarter and the final
quarter of the study, both D2B and C2B times decreased
significantly. It has previously been demonstrated that
longer treatment times are associated with increased mor-
tality. Data from the U.S. NRMI (National Registry of
Myocardial Infarction), with more than 29,000 STEMI
patients, demonstrated that increasing a target D2B time of
90 min in 15-min steps added 6.3 deaths to 1,000 otherwise
optimally treated patients (7). This would suggest that
reducing D2B time by 60 min would result in a calculated
number-needed-to-treat of 40 patients to prevent 1 death.
Recent prospective analyses have been consistent with this,
including 1 study with more than 43,000 patients that
showed that reducing D2B time from 90 to 60 min was
associated with lower mortality (8), raising questions about
the previous goal of a D2B time of 90 min (13–15).
By contrast, retrospective analyses and registries (7,16–19)
are subject to some confounding. For example, the associ-
ation between longer treatment times and adverse outcomes
may be exacerbated by longer procedure times in higher-risk
patients. We addressed this in the present study by prospec-
tively calculating a TIMI risk score (20) and by including all
patients presenting with STEMI (21). Including high-risk
patients, such as those in cardiogenic shock and those with
cardiac arrest, may explain the greater overall in-hospital
and 30-day mortality rates seen in the present study when
compared with most recent trials and large registries. We
demonstrated that enhanced feedback reduces treatment
times associated with reduced mortality, and that this effect
is more prominent in patients at high risk, with the greatest
decrease in mortality in patients with TIMI risk score 3.
Several factors may have contributed to achieving the goal
of reduced treatment times. Participants in the quarterly
feedback sessions came from several departments, including
the ED, and included physicians and nonphysicians. Inclu-
sive and interactive sessions could have resulted in better
understanding of the whole treatment process, understand-
ing the importance of individuals’ roles in the treatment
process (“buy-in”), and team cohesiveness (22,23).
Our study showed the largest improvement in treatment
times in patients who presented to the PCI hospital by
primary transport or as self-referrals. We did not see a
reduction in the first D2B time and in C2B time of patients
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854who underwent secondary transport, and no improvement
in mortality was observed in this group of patients. This is
in contrast to the initial study by Scholz et al. (10). One
Table 2. Time Intervals (Min) for All Patients With STEMI and PCI: Quarter
All Patients With STEMI and PCI N  1,002
Patients With P
N  679
Onset of symptoms to ﬁrst medical contact Mean
Interval from emergency call to arrival of emergency responder Mean
Initial treatment on location Mean
Duration of transportation by ambulance Mean
Interval from arrival in invasive-treatment center to arrival in cath lab Mean
Interval from arrival in cath lab to puncture Mean
Interval from puncture to ﬁrst balloon inﬂation Mean
Door-to-balloon (PCI hospital) Mean
Contact-to-balloon Mean
Patients With Secondary Tra
N  228
Onset of symptoms to ﬁrst medical contact Mean
Interval from arrival in non-PCI hospital to arrival in PCI hospital
(door-to-door)
Mean
Interval from arrival in invasive treatment center to arrival in cath lab Mean
Interval from arrival in cath lab to puncture Mean
Interval from puncture to ﬁrst balloon inﬂation Mean
First door-to-balloon Mean
Door-to-balloon (PCI hospital) Mean
Contact-to-balloon Mean
Transfer Patients With Primary (In
N  109
Onset of symptoms to ﬁrst medical contact Mean
Interval from emergency call to arrival of emergency responder Mean
Initial treatment on location Mean
Duration of transportation by ambulance to non-PCI hospital Mean
Interval from arrival in non-PCI hospital to arrival in PCI hospital
(door-to-door)
Mean
Door-to-balloon (PCI hospital) Mean
Contact-to-balloon Mean
Patients With Self
N  78
Onset of symptoms to ﬁrst medical contact Mean
Interval from arrival in invasive-treatment center to arrival in cath lab Mean
Interval from arrival in cath lab to puncture Mean
Interval from puncture to ﬁrst balloon inﬂation Mean
Contact-to-balloon Mean
Cath lab catheterization lab; other abbreviations as in Table 1.difference is that feedback presentations in the earlier studywere held, not only at the PCI site, but also in the associated
nearby non-PCI hospitals. Whether extending feedback to
referring community hospitals is feasible in larger myocar-
Quarter 5
uarter 1
 226)
Quarter 2
(n  190)
Quarter 3
(n  197)
Quarter 4
(n  195)
Quarter 5
(n  194)
p Value
(Q1 vs. Q5)
Transportation
uarter 1
 153)
Quarter 2
(n  120)
Quarter 3
(n  132)
Quarter 4
(n  127)
Quarter 5
(n  147)
3 244 191 278 206 302 135 194 172 263 0.48
.6 5.4 8.2 4.9 8.2 3.9 8.8 4.6 8.9 5.7 0.98
7 13 24 13 24 17 27 13 25 12 0.06
8 12 15 11 19 13 20 13 17 12 0.32
8 80 39 43 26 29 32 47 33 38 0.0003
1 6.1 11 7.9 10 5.7 10 6.4 11 7 0.43
6 15 22 11 23 14 21 12 21 8.6 0.02
4 86 71 47 60 35 63 55 66 40 0.0003
0 88 110 50 102 41 110 57 108 45 0.00009
ation (All Transfer Patients)
uarter 1
 56)
Quarter 2
(n  53)
Quarter 3
(n  40)
Quarter 4
(n  46)
Quarter 5
(n  33)
0 291 230 294 242 278 277 364 149 182 0.02
5 176 141 118 172 215 143 105 153 156 0.99
5 46 17 23 22 47 20 24 27 39 0.09
2 5 12 6.1 10 4 11 5.3 11 3.6 0.21
1 11 24 18 22 17 21 8.1 26 19 0.40
3 186 195 131 226 213 195 118 217 158 0.93
8 49 54 33 55 53 52 30 64 43 0.88
9 194 213 130 245 211 213 119 226 156 0.92
ransportation to Non-PCI Hospital
uarter 1
 28)
Quarter 2
(n  25)
Quarter 3
(n  22)
Quarter 4
(n  25)
Quarter 5
(n  9)
1 305 187 269 312 334 202 260 55 52 0.003
8 3.9 12 7.6 8.7 3.3 8.2 4.1 6.8 3.3 0.44
1 10 20 11 23 13 21 8 26 7 0.13
2 17 21 20 15 7.7 13 8 6 5 0.16
1 212 128 102 139 121 129 102 112 43 0.99
0 49 46 26 53 43 52 27 56 35 0.59
4 227 212 120 229 132 214 114 200 60 0.69
al to PCI Hospital
uarter 1
 16)
Quarter 2
(n  13)
Quarter 3
(n  22)
Quarter 4
(n  15)
Quarter 5
(n  12)
2 358 309 272 359 399 206 253 162 183 0.07
0 50 92 89 90 78 54 21 40 19 0.015
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855ments in treatment times for secondary transport patients
have also been documented by Blankenship et al. (24). In
that study of 676 patients in a rural setting in Pennsylvania,
the investigators were able to reduce their median first D2B
time from 189 to 88 min over a time range of 5 years by
implementing a program of rapid triage, transfer, and
treatment of patients presenting at 19 non-PCI hospitals.
Thus, there is huge potential to improve treatment times in
patients with secondary transport when non-PCI hospitals
are reached more effectively. In fact, analysis of U.S. data
from 2005 and 2006 revealed that a first D2B time of 120
min was achieved in only 36.3% of patients (25). By
contrast, in a limited setting involving only 1 referral
hospital and 1 PCI hospital in Vermont, 94% of STEMI
patients achieved a first D2B time of 120 min (26). Our
data on secondary transport time trends are more difficult to
interpret because the participants in our study were encour-
aged to reduce the number of transfer patients by bypassing
the non-PCI hospital, and, correspondingly, the number of
patients with secondary transport decreased slightly over the
course of the study, increasing the group of primary trans-
port patients. It appears intuitive, but it remains to be
demonstrated that this approach would reduce treatment
times more effectively than would streamlining secondary
transport, especially when combined with pre-arrival notifica-
tion of the receiving PCI center. In fact, the most marked
improvements in treatment times in the present study were
seen in patients that were primarily transported with advance
notification of the PCI center, and in these patients, a
significant reduction in mortality was demonstrated.
Our data suggest that much of the additional time savings
associated with advance notification of the receiving PCI
center were due to reduced or eliminated stays in the ED.
Figure 4. Follow-Up (All STEMI Patients; N  1,183):
In-Hospital Mortality
Pat  patients; STEMI  ST-segment elevation myocardial infarction.This is consistent with prior data demonstrating thatreducing treatment time in the ED reduces D2B times and
myocardial infarct size (27). Overall, our data strongly suggest
that reducing the number of handoffs and aiming for primary
transport with advance notification and bypassing of the ED is
effective and can be achieved with the approach of inclusive
quarterly data analysis and feedback sessions.
Study limitations. Because the results of the pilot study were
known to the participants, there may have been an enhanced
degree of motivation for the participating networks (10).
This could affect baseline data as well as the degree of
improvement seen throughout the study. Further, this
study’s primary outcome was a nonclinical one, and the
study was not powered to detect changes in mortality, which
is the objective of an ongoing new larger trial focusing on
mortality as primary clinical endpoint (FITT-STEMI-2).
Finally, although there was a distinct association between
treatment times and the feedback intervention, causality can
only be hypothesized, and other factors, such as slight adjust-
ments in technique or changes in operator experience over
Figure 5. Subgroup of Patients With Primary Transport and
Advance Notification by Telephone (N  598)
(A) Mortality at 30 days follow-up. (B) Percentage of patients who
bypassed the emergency department with direct handoff by emergency
medical services at the catheterization laboratory (cath lab). Abbreviations
as in Figures 1 and 4.
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856time, may have contributed. However, the most marked
improvements in time were related to processes, such as
bypassing the ED. These processes were already encouraged as
part of institutional protocol at the beginning of the study, and
thus, the improvements seen were most likely due to the
reinforcement achieved through our intervention.
A limitation of the present study is that the intervention
under evaluation (i.e., systematic feedback) was not com-
pared contemporaneously with no-intervention cases. A
study design comparing different networks over time, some
with institution of feedback and some without, would
appear impractical because of the heterogeneity inherent in
different infarction networks. A follow-up study (FITT-
STEMI-2) has been designed to address this limitation by
including 2 baseline quarters per center. Long-term
follow-up data from the pilot network (10) revealed that
treatment times worsened when quarterly feedback was
discontinued (K. Scholz, personal communication, March
2012).
The improvements in “onset to symptoms to first medical
contact” observed in the smaller groups of transfer patients
(secondary transport) and patients with self-referral are
difficult to explain by the feedback analyzed yet could
influence overall long-term clinical outcome. Mortality,
however, remained unaltered in both groups.
Conclusions
The current trial shows that implementation of a systematic
data assessment and formalized data feedback is possible
across different regional STEMI networks, independent of
their specific setting. We were able to demonstrate a
significant reduction in C2B and D2B times after imple-
menting this feedback process. There was a significant
improvement in clinical outcomes, including 1-year mortal-
ity. We conclude that a formalized feedback process is an
effective intervention to improve treatment times for
STEMI and should complement the strategies of the
American College of Cardiology D2B initiative.
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